Skip to main navigation Skip to search Skip to main content

Biological evaluation of a multi-targeted small molecule inhibitor of tumor-induced angiogenesis

  • Lee A. McDermott
  • , Brian Higgins
  • , Mary Simcox
  • , Kin Chun Luk
  • , Tom Nevins
  • , Kenneth Kolinsky
  • , Melissa Smith
  • , Hong Yang
  • , Jia K. Li
  • , Yingsi Chen
  • , June Ke
  • , Navita Mallalieu
  • , Tom Egan
  • , Stan Kolis
  • , Aruna Railkar
  • , Louise Gerber
  • , Jin Jun Liu
  • , Fred Konzelmann
  • , Zhuming Zhang
  • , Tom Flynn
  • Omar Morales, Yi Chen

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Abstract

RO4396686 is a small molecule KDR, FGFR, and PDGFR inhibitor with good pharmacokinetic properties in rodents. In a mouse corneal neovascularization assay, this compound inhibited VEGF-induced angiogenesis. Tested in a H460a xenograft tumor model this agent effected significant tumor growth inhibition at doses as low as 50 mg/kg.

Original languageEnglish
Pages (from-to)1950-1953
Number of pages4
JournalBioorganic and Medicinal Chemistry Letters
Volume16
Issue number7
DOIs
StatePublished - 1 Apr 2006
Externally publishedYes

Keywords

  • Biological results
  • FGFR
  • Inhibitor
  • KDR
  • PDGFR
  • Pyrimidopyrimidone

Fingerprint

Dive into the research topics of 'Biological evaluation of a multi-targeted small molecule inhibitor of tumor-induced angiogenesis'. Together they form a unique fingerprint.

Cite this